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PHP21 THE ROLE OF MONETARY AND NON-MONETARY INCENTIVES ON THE CHOICE OF PRACTICE ESTABLISHMENT: A STATED PREFERENCE STUDY OF YOUNG PHYSICIANS IN GERMANY
Günther OH 1 , Kürstein B 2 , Riedel-Heller SG 3 , Koenig HH 2 1 i3 Innovus Berlin, Berlin, Germany, 2 University of Leipzig, Leipzig, Germany, 3 University of Leipzig, Leipzig, Saxony, Germany OBJECTIVES: Despite a growth in the total number of physicians in many industrialized countries, significant inequalities in their distribution exist between rural and inequalities in their distribution exist between rural and urban areas. Therefore, decision-makers need detailed information about young physicians' preferences in establishing a practice. The aim of the study was to quantify the preferences for different attributes relevant to practice establishment in Germany. METHODS: In the qualitative part of the study, in-depth interviews of 22 physicians were conducted to identify relevant practice attributes. Based on this information a questionnaire was developed containing a discrete choice experiment comprised ontaining a discrete choice experiment comprised of a "best-worst scaling" (BWS) task. It was mailed to a representative sample of 14,939 young physicians who were close to make a decision regarding practice establishment. Regression analysis was used to estimate utility weights quantifying physicians' preferences for practice attributes. RESULTS: From the qualitative part six attributes were identified relevant to practice establishment: "professional cooperation", "income", "career opportunities of the partner", "availability of child care", rtner", "availability of child care", "leisure activities", and "on-call duty". For the BWS task, 5026 returned questionnaires were analyzed. The results indicated that a change in income is most important to physicians. It would result in the largest utility change compared with changes in the remaining attributes. Physicians' preferences showed that the additional net income per month to compensate the disutility of a practice in a rural area was a9044 (US$11,938). Yet, non-monetary attributes as on-site availability of childcare and few $11,938). Yet, non-monetary attributes as on-site availability of childcare and few on-site availability of childcare and few on-call duty would decrease the additional income required to compensate the disutility of a rural practice. CONCLUSIONS: The results offer detailed and quantifiable information to health policy makers to develop tailored incentive-based interventions ailored incentive-based interventions to diminish urban-rural inequalities in physician coverage. Only a substantial rise in income increases the probability that young physicians establish a practice in more rural area.
PHP22 TOO MANY AGENCIES FOR DRUG EVALUATION IN SPAIN?
Collar JM Grunenthal Pharma, S.A., Madrid, Spain OBJECTIVES: Identify the health agencies/committees that are involved in new drug evaluations in Spain. METHODS: Search in the Spanish Health System and in the several Regional Health Systems databases the different agencies/committees that are developing new drug evaluations. RESULTS: Five regional drug evaluation committees which are working since late 2003 in a coordinated way are playing the main role of new drugs evaluations in the primary care (PC) setting, conforming a Joint Committe. Other 12 regions are publishing with different degrees of periodicity their own new drug information leaflets in the PC setting. In the hospital setting each centre has been autonomous for accepting or rejecting new drug applications into their own formularies, although there is a working group in the SEFH (Spanish Society of Hospital Pharmacy), named GENESIS, which is leading an initiative to have a common methodology for evaluating new drugs and to avoiding potential duplicities in drug evaluations in the hospital background. Besides, there are 7 different health technology agencies (1 national 6 regional) in Spain that rarely evaluate new drugs. CONCLU-SIONS: Spain has one of the biggest European framework of health technology agencies that is seldom used to develop new drug evaluations. In parallel, all the Regional Health Systems have developed their own new drug evaluation entities to evaluate drugs with a high potential consumption in the PC setting. Other initiatives have been developed to disminish potential evaluation duplicities either in the PC or in the hospital setting. Most of the new drugs evaluations are negative and focused to restrict the consumption of new drugs available in the market to control drug expenditure. , the processed antipsychotics in Croatia showed a continuous increase in prescribed DDD/1000 inh/day. Haloperidol, promazine and olanzapine were the most prescribed drugs. By collecting and analyzing data useful for the improvement of pharmacotherapy, we also obtain information for the many other factors essential for the rational health care.
PHP23 GENERAL PRACTITIONERS' PRESCRIPTIONS INDICATORS TRENDS, A TIME-SERIES REVIEW DURING 1998-2003 IN IRAN

